| 1 |
Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level |
|
|
| Kim, K.-A., Joo, H.-J., Park, J.-Y. |
|
| European Journal of Clinical Pharmacology. 2011; 67(2): 129-134 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Pharmacokinetic comparison and bioequivalence of two leflunomide formulations in humans: A single dose, randomized, open-label, two-way crossover study |
|
|
| Park, J.-Y., Kim, K.-A., Lee, Y.-H., Park, S.-W., Lee, G.-H., Ryu, J.-H. |
|
| International Journal of Clinical Pharmacology and Therapeutics. 2010; 48(4): 291-295 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Leflunomide |
|
|
| Mehta, V., Kisalay, S., Balachandran, C. |
|
| Indian Journal of Dermatology, Venereology and Leprology. 2009; 75(4): 422-424 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
New amides of 5-(4-chlorobenzoyl)aminoorotic acid: Their synthesis and biological activity |
|
|
| Regiec, A., Śpiewak, M., Jasztold-Howorko, R., Miȩdzybrodzki, R. |
|
| Archiv der Pharmazie. 2008; 341(11): 677-689 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Treatment of lupus nephritis: Facing the era of immunotherapy |
|
|
| Aran, A.A., Putterman, C. |
|
| Panminerva Medica 50. 2008; 50(3): 235-245 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Leflunomide and acute hypocalcemia |
|
|
| Young, M.G., Rijhsinghani, S. |
|
| Endocrine Practice. 2007; 13(7): 805-807 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
38 Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs |
|
|
| Braun, F., Behrend, M. |
|
| Side Effects of Drugs Annual. 2007; 29: 424-479 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Treatment of proliferative lupus nephritis - A critical approach |
|
|
| Buhaescu I, Covic A, Deray G |
|
| SEMINARS IN ARTHRITIS AND RHEUMATISM. 2007; 36 (4): 224-237 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Clinical efficacy and adverse effects of weekly single dose leflunomide in refractory rheumatoid arthritis |
|
|
| Paul, B.J., Thachil, E.J., Jayachandran, N.V., Radhakrishnan, S. |
|
| Indian Journal of Rheumatology. 2007; 2(1): 3-7 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Synthesis and biological activity of 4-amino-1-methyl-5-imidazolecarboxylic acid derivatives |
|
|
| Regiec, A., Mastalarz, H., Miedzybrodzki, R., Śmietańska, K., Jasztold-Howorko, R. |
|
| Letters in Drug Design and Discovery. 2006; 3(3): 192-199 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis | [Hautulzerationen nach leflunomid therapie bei zwei patienten mit rheumatoidarthritis] |
|
|
| Jakob, A., Porstmann, R., Rompel, R. |
|
| JDDG - Journal of the German Society of Dermatology. 2006; 4(4): 324-327 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Leflunomide and azathioprine combination in refractory Adult-onset Stills disease |
|
|
| Cefle A |
|
| ANNALS OF PHARMACOTHERAPY. 2005; 39 (4): 764-767 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Systemic vasculitis: Still a challenging disease |
|
|
| Buhaescu, I., Covic, A., Levy, J. |
|
| American Journal of Kidney Diseases. 2005; 46(2): 173-185 |
|
| [Pubmed] [Google Scholar] |
|
